Community, hospital and hospice based. MLD: manual lymphatic drainage. Strategic Project Management Made Simple Ebook Covers. 2 BEST PRACTICE FOR THE MANAGEMENT OF LYMPHOEDEMA. Krizz Kaliko Vitiligo Rarest.

A is a basic component of intermittent pneumatic compression (IPC), a widely used technique that involves attaching an electrical air compression pump to an inflatable plastic garment that is placed over the affected limb. The garment is inflated and deflated cyclically for a set period, usually about 30–120 minutes. The pressure produced by the garment can be varied. Garments may be single chambered or contain multiple chambers (usually 3, 5, or 10) that are inflated sequentially to provide a peristaltic massaging effect along the length of the limb.

Study Purpose: To examine the insurance data of cancer survivors to determine lymphedema prevalence and to assess the affect on specific clinical health outcomes and healthcare costs after the receipt of a pneumatic compression device (PCD) among the identified study group of cancer survivors with lymphedema Intervention Characteristics/Basic Study Process: The researchers performed a retrospective analysis of health claims data from 2007–2013. D-identified administrative health claims data from deidentified Normative Health Information (dNHI) database (34 million insured) were used through OptumInsight.

Researchers did not have access to the data but rather instructed Optum employees to cull the data. • ICD-9 codes were used to select patients with cancer. • ICD-9 codes for lymphedema (457. Avid Pro Tools 9 Free Download Full + Crack Windows. 0, 457.1, and 757.0) were sought among the patients with cancer.

• The Healthcare Common Procedure Coding System (HCPCS) codes for a PCD, E0651, or E0652 were searched among patients with cancer and lymphedema. • Every participant was required to have had 12 months of insurance coverage prior to the receipt of a PCD, which then carried through another 12 months. • Any patients who received a replacement pump were excluded.

Sample Characteristics: • N = 1,065 • AGE = 9.2% aged 19–44 years, 53.2% aged 45–64 years, and 37.6% aged 65 years or older • MALES: 20%, FEMALES: 80% • CURRENT TREATMENT: Not applicable • KEY DISEASE CHARACTERISTICS: Patients with cancer with insurance for 12 months prior to and after the receipt of a PCD (index date). Baseline period was 12 months prior to receipt of the pump. Follow-up was 12 months after receipt of the pump. • OTHER KEY SAMPLE CHARACTERISTICS: Nineteen percent were obese. Setting: • SITE: Multi-site • SETTING TYPE: Not specified • LOCATION: USA Study Design: A retrospective study of insurance data from 2007–2013.

The researchers compared the rate of identified clinical healthcare outcomes and their costs in each setting for the year prior to the receipt of a PCD to the rates and costs after receipt of the PCD. Measurement Instruments/Methods: After the sample was identified, the affect of the receipt of the PCD was determined by searching for specific claims codes and their costs during the 12 months before and after receipt of the PCD. Specific health outcomes, such as hospitalization, outpatient visits, physical therapy, episodes of cellulitis, and courses of lymphedema physical therapy, were determined by the American Medical Association place of service codes, and the clinical costs were designated as lymphedema related if the primary or secondary diagnoses were ICD-9: 457.0, 457.1, 757.0. Total cost was the sum of the payments for lymphedema claims. Continuous variables were tested pre PCD minus post PCD with a paired t test.